PharmaNet/i3 Ensures IT License Compliance, Lowers Costs by US$380,000 with Proactive License Management Review
 
 

PharmaNet/i3 Ensures IT License Compliance, Lowers Costs by US$380,000 with Proactive License Management Review

Printer View Printer View

PharmaNet/i3 works with pharmaceutical, biotechnology, generic drug, and medical device companies to offer a full range of bioanalytical, Phase I-III clinical trial, regulatory, and phase IV postmarketing services to the life sciences industry. The company has a breadth of global resources and expertise in clinical trials for all major therapeutic areas to better serve its diverse customer base—from organizations running a single, local study, to large, clinical trial programs, spanning multiple continents.

PharmaNet/i3 runs many of its clinical applications―such as Oracle Clinical, Oracle Remote Data Capture, and Oracle Thesaurus Management System―on Oracle Database 11g and Oracle WebLogic Server. In addition, the company has developed an in-house pharmacovogilance system that also runs on Oracle Database. To reduce organizational risk and advance its competitive advantage in the market, the company works to ensure that it is in compliance with its Oracle asset licenses. The company engages with Oracle License Management Services to expand its knowledge of its Oracle assets and ensure license compliance. PharmaNet/i3 has also reduced licensing costs. In one instance, Oracle License Management Services helped the company save more than US$380,000 in licensing costs by determining that it was eligible to run less expensive, named-user licenses, as opposed to central processing unit (CPU)-based licenses in its staging and development environments.

 
 

 
 

Challenges

A word from PharmaNet/i3

  • “Oracle License Management Services provided us with best practices to understand our license assets, reviewed our deployment for compliance, and built a planned approach for the ongoing management of our Oracle products. We even discovered that we were eligible for less expensive named-user licenses in our staging and development environments, saving us US$380,000.” – Ahmed Shehata, IT Director, PharmaNet/i3

  • Ensure the company is in compliance with the Oracle Database 11g licenses it purchases on behalf of clinical trial customers
  • Enable the company to optimize Oracle product license pricing for its staging, development, and production IT environments, including its clinical trial application environments—all of which have different licensing schema and requirements

Solutions

Oracle Product and Services

  • Engaged with Oracle License Management Services to conduct an audit of the company’s Oracle licenses to ensure compliance and avoid the risk of penalty for the company and its customers
  • Enabled the company, via improved education, to certify to potential and current customers—which include risk-averse pharmaceutical and medical device companies— that it is an Oracle-compliant shop, raising its credibility and reducing operational risk while helping to distinguish the company from its competition in the marketplace
  • Reduced licensing costs associated with the company’s staging and development environments that can use less expensive named-user licenses as opposed to CPU-based licensing, which saved the company more than US$380,000 in license costs
  • Gained knowledge about how purchase date impacts licensing costs for Oracle WebLogic servers, and was able take advantage of savings on several servers